Protein aggregate-ligand binding assays based on microfluidic diffusional separation by Zhang, Y, Buell, A, Müller, T, De Genst, E, Benesch, J, Dobson, C, Knowles, T

Silk micrococoons for protein stabilisation and molecular encapsulation by Vollrath, F, Porter, D, Shimanovich, U, Ruggeri, S, de Genst, E, Adamcik, J, Barros, T, Müller, T, Mezzenga, R, Dobson, C, Holland, C, Knowles, T

A non-natural variant of human lysozyme (I59T) mimics the in vitro behaviour of the I56T variant that is responsible for a form of familial amyloidosis. by Hagan, C, Johnson, R, Dhulesia, A, Dumoulin, M, Dumont, J, De Genst, E, Christodoulou, J, Robinson, C, Dobson, C, Kumita, JR

The significance of the location of mutations for the native-state dynamics of human lysozyme by Ahn, M, Hagan, C, Bernardo-Gancedo, A, De Genst, E, Newby, F, Christodoulou, J, Dhulesia, A, Dumoulin, M, Robinson, C, Dobson, C, Kumita, J

A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation. by De Genst, E, Chan, P, Pardon, E, Hsu, S, Kumita, JR, Christodoulou, J, Menzer, L, Chirgadze, D, Robinson, C, Muyldermans, S, Matagne, A, Wyns, L, Dobson, C, Dumoulin, M

Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils. by Chan, P, Pardon, E, Menzer, L, De Genst, E, Kumita, JR, Christodoulou, J, Saerens, D, Brans, A, Bouillenne, F, Archer, D, Robinson, C, Muyldermans, S, Matagne, A, Redfield, C, Wyns, L, Dobson, C, Dumoulin, M